US FDA’s Foreign Inspection Agenda: Visit The 1,000 Facilities It’s Never Seen
Executive Summary
Congressional oversight agency urges FDA to make better use of foreign offices with more effective performance measures and staffing goals; GAO notes agency’s progress towards risk-based inspections – and its plan to revisit every site at least once every five years.
You may also be interested in...
US FDA Could Use More Foreign Investigators If It Could Find Them, Woodcock Says
Hiring travails, inspection pre-announcement, lack of translators highlighted in congressional hearing on FDA foreign inspections.
US FDA's Brexit: One Staffer Moving, But Impact Still May Loom Large
Uncertainty about Brexit's impact on the FDA-EMA mutual recognition agreement are among issues worrying regulators as countdown continues to the UK's departure from the EU.
US FDA's Inspection Decisions To Be Swayed By Facility "History" With Foreign Regulators
Leveraging foreign surveillance inspections could help FDA ensure more sites are inspected more often.